カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のフェロジピン徐放性錠剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Felodipine Sustained-Release Tablet Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22MY8818）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22MY8818
■ 発行日：2022年5月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥522,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥783,000見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,044,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のフェロジピン徐放性錠剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

フェロジピン徐放性錠剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のフェロジピン徐放性錠剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

フェロジピン徐放性錠剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・1錠あたり2.5mg、1錠あたり5mg、その他

用途別セグメントは次のように区分されます。
・高血圧治療、狭心症緩和、その他

世界のフェロジピン徐放性錠剤市場の主要な市場プレーヤーは以下のとおりです。
・Astrazeneca、NanJing Easeheal Phaemaecutical、SHANXI KANGBO BIOLOGICAL PRODUCT、Lifeon、Changzhou Siyao Pharmaceutical、Mylan、Sandoz

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、フェロジピン徐放性錠剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なフェロジピン徐放性錠剤メーカーの企業概要、2019年～2022年までのフェロジピン徐放性錠剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なフェロジピン徐放性錠剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別フェロジピン徐放性錠剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのフェロジピン徐放性錠剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのフェロジピン徐放性錠剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびフェロジピン徐放性錠剤の産業チェーンを掲載しています。
・第13、14、15章では、フェロジピン徐放性錠剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Astrazeneca、NanJing Easeheal Phaemaecutical、SHANXI KANGBO BIOLOGICAL PRODUCT、Lifeon、Changzhou Siyao Pharmaceutical、Mylan、Sandoz
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：1錠あたり2.5mg、1錠あたり5mg、その他
・用途別分析2017年-2028年：高血圧治療、狭心症緩和、その他
・フェロジピン徐放性錠剤の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・フェロジピン徐放性錠剤のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・フェロジピン徐放性錠剤のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・フェロジピン徐放性錠剤の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・フェロジピン徐放性錠剤の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Felodipine Sustained-Release Tablet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Felodipine Sustained-Release Tablet market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Treat High Blood Pressure accounting for % of the Felodipine Sustained-Release Tablet global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 2.5mg Per Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Felodipine Sustained-Release Tablet include Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, Lifeon, and Changzhou Siyao Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Felodipine Sustained-Release Tablet market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
2.5mg Per Tablet
5mg Per Tablet
Others
Market segment by Application can be divided into
Treat High Blood Pressure
Relieve Angina
Others
The key market players for global Felodipine Sustained-Release Tablet market are listed below:
Astrazeneca
NanJing Easeheal Phaemaecutical
SHANXI KANGBO BIOLOGICAL PRODUCT
Lifeon
Changzhou Siyao Pharmaceutical
Mylan
Sandoz
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Felodipine Sustained-Release Tablet product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Felodipine Sustained-Release Tablet, with price, sales, revenue and global market share of Felodipine Sustained-Release Tablet from 2019 to 2022.
Chapter 3, the Felodipine Sustained-Release Tablet competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Felodipine Sustained-Release Tablet breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Felodipine Sustained-Release Tablet market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Felodipine Sustained-Release Tablet.
Chapter 13, 14, and 15, to describe Felodipine Sustained-Release Tablet sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Felodipine Sustained-Release Tablet Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Felodipine Sustained-Release Tablet Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 2.5mg Per Tablet
1.2.3 5mg Per Tablet
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Felodipine Sustained-Release Tablet Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Treat High Blood Pressure
1.3.3 Relieve Angina
1.3.4 Others
1.4 Global Felodipine Sustained-Release Tablet Market Size & Forecast
1.4.1 Global Felodipine Sustained-Release Tablet Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Felodipine Sustained-Release Tablet Sales in Volume (2017-2028)
1.4.3 Global Felodipine Sustained-Release Tablet Price (2017-2028)
1.5 Global Felodipine Sustained-Release Tablet Production Capacity Analysis
1.5.1 Global Felodipine Sustained-Release Tablet Total Production Capacity (2017-2028)
1.5.2 Global Felodipine Sustained-Release Tablet Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Felodipine Sustained-Release Tablet Market Drivers
1.6.2 Felodipine Sustained-Release Tablet Market Restraints
1.6.3 Felodipine Sustained-Release Tablet Trends Analysis
2 Manufacturers Profiles
2.1 Astrazeneca
2.1.1 Astrazeneca Details
2.1.2 Astrazeneca Major Business
2.1.3 Astrazeneca Felodipine Sustained-Release Tablet Product and Services
2.1.4 Astrazeneca Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 NanJing Easeheal Phaemaecutical
2.2.1 NanJing Easeheal Phaemaecutical Details
2.2.2 NanJing Easeheal Phaemaecutical Major Business
2.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product and Services
2.2.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 SHANXI KANGBO BIOLOGICAL PRODUCT
2.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Details
2.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Major Business
2.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product and Services
2.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Lifeon
2.4.1 Lifeon Details
2.4.2 Lifeon Major Business
2.4.3 Lifeon Felodipine Sustained-Release Tablet Product and Services
2.4.4 Lifeon Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Changzhou Siyao Pharmaceutical
2.5.1 Changzhou Siyao Pharmaceutical Details
2.5.2 Changzhou Siyao Pharmaceutical Major Business
2.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product and Services
2.5.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Felodipine Sustained-Release Tablet Product and Services
2.6.4 Mylan Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business
2.7.3 Sandoz Felodipine Sustained-Release Tablet Product and Services
2.7.4 Sandoz Felodipine Sustained-Release Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Felodipine Sustained-Release Tablet Breakdown Data by Manufacturer
3.1 Global Felodipine Sustained-Release Tablet Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Felodipine Sustained-Release Tablet Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Felodipine Sustained-Release Tablet
3.4 Market Concentration Rate
3.4.1 Top 3 Felodipine Sustained-Release Tablet Manufacturer Market Share in 2021
3.4.2 Top 6 Felodipine Sustained-Release Tablet Manufacturer Market Share in 2021
3.5 Global Felodipine Sustained-Release Tablet Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Felodipine Sustained-Release Tablet Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Felodipine Sustained-Release Tablet Market Size by Region
4.1.1 Global Felodipine Sustained-Release Tablet Sales in Volume by Region (2017-2028)
4.1.2 Global Felodipine Sustained-Release Tablet Revenue by Region (2017-2028)
4.2 North America Felodipine Sustained-Release Tablet Revenue (2017-2028)
4.3 Europe Felodipine Sustained-Release Tablet Revenue (2017-2028)
4.4 Asia-Pacific Felodipine Sustained-Release Tablet Revenue (2017-2028)
4.5 South America Felodipine Sustained-Release Tablet Revenue (2017-2028)
4.6 Middle East and Africa Felodipine Sustained-Release Tablet Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Felodipine Sustained-Release Tablet Sales in Volume by Type (2017-2028)
5.2 Global Felodipine Sustained-Release Tablet Revenue by Type (2017-2028)
5.3 Global Felodipine Sustained-Release Tablet Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Felodipine Sustained-Release Tablet Sales in Volume by Application (2017-2028)
6.2 Global Felodipine Sustained-Release Tablet Revenue by Application (2017-2028)
6.3 Global Felodipine Sustained-Release Tablet Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
7.2 North America Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
7.3 North America Felodipine Sustained-Release Tablet Market Size by Country
7.3.1 North America Felodipine Sustained-Release Tablet Sales in Volume by Country (2017-2028)
7.3.2 North America Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
8.2 Europe Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
8.3 Europe Felodipine Sustained-Release Tablet Market Size by Country
8.3.1 Europe Felodipine Sustained-Release Tablet Sales in Volume by Country (2017-2028)
8.3.2 Europe Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
9.2 Asia-Pacific Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
9.3 Asia-Pacific Felodipine Sustained-Release Tablet Market Size by Region
9.3.1 Asia-Pacific Felodipine Sustained-Release Tablet Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Felodipine Sustained-Release Tablet Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
10.2 South America Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
10.3 South America Felodipine Sustained-Release Tablet Market Size by Country
10.3.1 South America Felodipine Sustained-Release Tablet Sales in Volume by Country (2017-2028)
10.3.2 South America Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Type (2017-2028)
11.2 Middle East & Africa Felodipine Sustained-Release Tablet Sales by Application (2017-2028)
11.3 Middle East & Africa Felodipine Sustained-Release Tablet Market Size by Country
11.3.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Felodipine Sustained-Release Tablet Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Felodipine Sustained-Release Tablet and Key Manufacturers
12.2 Manufacturing Costs Percentage of Felodipine Sustained-Release Tablet
12.3 Felodipine Sustained-Release Tablet Production Process
12.4 Felodipine Sustained-Release Tablet Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Felodipine Sustained-Release Tablet Typical Distributors
13.3 Felodipine Sustained-Release Tablet Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の生体内徐放性コーティング剤市場2022年：市場規模予測（～2028年）
  • 世界の徐放性用機能性ポリマー市場2022年：市場規模予測（～2028年）
  • 眼科用徐放性ドラッグデリバリーシステムのグローバル市場展望 2023年-2029年：リポソーム、マイクロカプセル/ナノカプセル、マイクロスフィア/ナノスフィア、インプラント
  • ジクロフェナクナトリウム徐放性カプセルの世界市場2023年：仕様0.25g、仕様0.5g
  • フェロジピンの世界市場インサイト・予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22MY8818 )"世界のフェロジピン徐放性錠剤市場2022年：市場規模予測（～2028年）" (英文：Global Felodipine Sustained-Release Tablet Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。